ICERs: metformin | |||||||
Metformin: ICER in 2015 GBP Health system perspective | Metformin: ICER in 2015 GBP Societal perspective | ||||||
Reference | Duration of analysis | Range (base case) | Mean | Unit | Range (base case) | Mean | Unit |
49 | Lifetime | 29 409 | 29 409 | £/QALY | |||
48 | 30 years | 32 430 | 32 430 | £/QALY | 33 392 | 33 392 | £/QALY |
40 | 10 years | Cost saving | Cost saving | £/QALY | Cost saving | Cost saving | £/QALY |
57 | Lifetime | 5477 | 5477 | £/QALY | |||
58 | 3 years | 15 371 | 15 371 | £/QALY | 4648 | 4648 | £/QALY |
54 | 50 years | 8428 | 8428 | £/QALY | |||
28 | Lifetime | 332 | 332 | £/QALY | |||
61 | 10 years | 15 339 | 15 339 | £/QALY | Cost saving (−10 735) | Cost saving (−10 735) | £/QALY |
47 | Lifetime simulation | 7290 | 7290 | £/LYG | |||
46 | 10 years | Cost saving (−5495) | Cost saving (−5495) | £/LYG | |||
55 | Age 100 or death | 14 960 | 14 960 | £/DALY | |||
60 | 3 years | 16 296 | 16 296 | Cost per case of T2DM avoided | 27 281 | 27 281 | Cost per case of T2DM avoided |
DALY, disability-adjusted life-years; DPP, Diabetes Prevention Program; GBP, British pounds; LYG, life-years gained; QALY, quality-adjusted life-years; T2DM, Type 2 Diabetes Mellitus.